Who Is Receiving the Oncotype Dx Breast Cancer Assay in Current Practice?

被引：0
|
作者：
Hosseini, Ava [1 ]
Baker, Jennifer L. [1 ]
Tokin, Christopher [1 ]
Mailey, Brian [1 ]
Wallace, Anne M. [1 ]
机构：
[1] UCSD, La Jolla, CA USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2014年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：59 / 59
页数：1
相关论文
共 50 条
  • [1] Routine practice use of Oncotype Dx assay in French breast cancer patients
    Wassermann, J.
    Toledano, A.
    Gligorov, J.
    Conforti, R.
    Grapin, J. P.
    Benothman, S.
    Spano, J. P.
    Khayat, D.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S323 - S323
  • [2] ECONOMIC ASSESSMENT OF THE ONCOTYPE DX BREAST CANCER ASSAY
    Escalona, S.
    Callejo, D.
    Blasco, J. A.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A424 - A424
  • [3] Spotlight on the utility of the Oncotype DX® breast cancer assay
    Siow, Zhen Rong
    De Boer, Richard H.
    Lindeman, Geoffrey J.
    Mann, G. Bruce
    [J]. INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2018, 10 : 89 - 100
  • [4] The impact of Oncotype DX breast cancer assay results on clinical practice: a UK experience
    Crolley, Valerie E.
    Marashi, Husam
    Rawther, Shabbir
    Sirohi, Bhawna
    Parton, Marina
    Graham, Janine
    Vinayan, Anup
    Sutherland, Stephanie
    Rigg, Anne
    Wadhawan, Anshu
    Harper-Wynne, Catherine
    Spurrell, Emma
    Bond, Hannah
    Raja, Fharat
    King, Judy
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2020, 180 (03) : 809 - 817
  • [5] The impact of Oncotype DX breast cancer assay results on clinical practice: a UK experience
    Valerie E. Crolley
    Husam Marashi
    Shabbir Rawther
    Bhawna Sirohi
    Marina Parton
    Janine Graham
    Anup Vinayan
    Stephanie Sutherland
    Anne Rigg
    Anshu Wadhawan
    Catherine Harper-Wynne
    Emma Spurrell
    Hannah Bond
    Fharat Raja
    Judy King
    [J]. Breast Cancer Research and Treatment, 2020, 180 : 809 - 817
  • [6] The Impact of Oncotype DX Breast Cancer Assay Results on Clinical Practice - a UK Experience
    Crolley, V.
    Rawther, S.
    Chaabouni, N.
    Rigg, A.
    Wadhawan, A.
    King, J.
    [J]. CLINICAL ONCOLOGY, 2017, 29 (06) : E98 - E99
  • [7] The impact of Oncotype DX breast cancer assay results on clinical practice: A UK experience
    Crolley, V. E.
    Marashi, H.
    Rawther, S. K. R.
    Parton, M.
    Graham, J.
    Vinayan, A.
    Sutherland, S.
    Rigg, A.
    Wadhawan, A.
    Harper-Wynne, C.
    Spurrell, E.
    Bond, H.
    Raja, F.
    King, J.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [8] The impact of Oncotype DX breast cancer assay results on clinical practice: a UK experience
    Crolley, Valerie E.
    Marashi, Husam
    Rawther, Shabbir Khan Rajan
    Sirohi, Bhawna
    Parton, Marina
    Graham, Janine
    Vinayan, Anup
    Sutherland, Stephanie
    Rigg, Anne
    Wadhawan, Anshu
    Harper-Wynne, Catherine
    Spurrell, Emma
    Bond, Hannah
    Raja, Fharat
    King, Judy
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2020, 180 (02) : 557 - 558
  • [9] The Oncotype DX® assay use in breast cancer in an Australian institutional setting
    Choi, J. D. W.
    Hughes, T. M. D.
    Marx, G.
    Boyages, J.
    Rutovitz, J.
    Hasovits, C.
    Parasyn, A.
    Edirimanne, S.
    Ngui, N. K.
    [J]. BREAST, 2021, 56 : S66 - S67
  • [10] Oncotype Dx assay impact on decision making chemotherapy in breast cancer
    Muhibullah, N.
    Khout, H.
    Whisker, L.
    Gutteridge, E.
    [J]. BRITISH JOURNAL OF SURGERY, 2017, 104 : 29 - 29
12345